MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AbCellera Biologics (ABCL) Ownership - Who owns AbCellera Biologics?

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
150 W 4th Avenue
Phone
+1 604 559-9005
Employees
562
Web
https://www.abcellera.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.51B
P/E Ratio
N/A
Total Cash
533.83M
Projected Growth
N/A
Total Debt
143.22M
Revenue
75.13M
Risk (Beta)
2.10
Dividend Yield
N/A
Total Cash/Share
1.75
Total Debt/Equity
N/A
Revenue/Share
0.26 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ABCL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for ABCL
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
150 W 4th Avenue
Phone
+1 604 559-9005
Employees
562
Web
https://www.abcellera.com